Breast Cancer Screening Market Was Estimated to Be Valued at USD 2.5 Billion in 2019 And Is Projected to Grow at A CAGR of 8.4% During The Forecast Period 2020-2027

The global breast cancer screening market was estimated to be valued at USD 2.5 billion in 2019 and is projected to grow at a CAGR of 8.4% during the forecast period 2020-2027. Growing incidence of breast cancer leading to an increase in breast cancer diagnostics and the introduction of innovative breast cancer screening procedures are the key factors anticipated to drive the breast cancer screening market during the forecast period. The rise in prevalence of breast cancer majorly among women of age group between 50 -70 years is significantly impacting the market growth.

Key screening techniques, majorly mammography and breast ultrasound screening are highly used for diagnosing early-stage breast cancer, which in turn boosts the market growth. According to the U.S. Breast Cancer Statistics, in 2020, approximately 276,480 new invasive breast cancer cases are projected to be diagnosed in U.S. women coupled with 48,530 new non-invasive breast cancer cases. In terms of technology, there is a significant demand in terms of value for the mammography screening procedure followed by ultrasound screening by the physicians. This is due to the high convenience and user-friendly attributes of this technology along with ultrasound and contrast-enhanced magnetic resonance imaging (MRI) playing an important role in diagnostics, staging, and follow-up of breast cancer.

Download FREE Sample Copy of Breast Cancer Screening Market Report @ https://crediblemarkets.com/sample-request/breast-cancer-screening-market-674088?utm_source=Pramod&utm_medium=OpenPR

Nearly 42,170 deaths among U.S. women are expected to occur from breast cancer in 2020. Death rates were registered to be steady in women below age 50 since 2007, but an eventual drop has been witnessed in women above age 50. The overall mortality rate associated with breast cancer decreased by nearly 1.3% per year between 2013 and 2017. This decline in breast cancer prevalence is attributed to treatment advances and earlier detection through screening. This is anticipated to boost the demand for Breast Cancer Screening, thereby driving the market growth.

Due to the recent outbreak of COVID-19, hospitals have limited their resources and staff, which is likely to negatively impact the breast cancer screening market owing to prolonged delay in surgeries and other medical procedures due to COVID-19. In severely affected regions such as North America and European countries, the influx of COVID-19 patients requiring continuous monitoring is increasing rapidly which leads to increased workload in hospital systems, thereby disrupting the routine treatment of cancer patients along with screening procedures.

Segments Covered in the Report-
Screening Type (Revenue, USD Million, 2016 – 2027)
• Mammography screening
• Ultrasound screening
• Magnetic Resonance Imaging (MRI) screening

End-Use Type (Revenue, USD Million, 2016 – 2027)
• Hospitals and clinics
• Diagnostic centers
• Research and academic institutes,
• Others

Regions covered in global Breast Cancer Screening market report-
• North America
• Latin America
• Europe
• the Asia Pacific
• Middle East & Africa

Direct Purchase Breast Cancer Screening Market Research Report Now @ https://crediblemarkets.com/reports/purchase/breast-cancer-screening-market-674088?utf8=%E2%9C%93&license_type=single_user&utm_source=Pramod&utm_medium=OpenPR

Some Points from Table of Content

Breast Cancer Screening Market Size, And Revenue Share Analysis By Screening Type (Mammography, Ultrasound, and Magnetic Resonance Imaging (MRI)), By End Use, - Global Forecasts, 2016 - 2027

Chapter 1 Breast Cancer Screening Market Overview 13
1.1 Product Overview and Scope of Breast Cancer Screening 13
1.2 Classification of Breast Cancer Screening by Type 13
1.2.1 Global Breast Cancer Screening Market Revenue Comparison by Type (2019-2026) 13
1.2.2 Global Breast Cancer Screening Revenue Market Share by Type in 2019 14
1.2.3 Mammography Screening 15
1.2.4 Breast Magnetic Resonance Imaging (MRI) Screening 16
1.2.5 Breast Ultrasound Screening 17
1.3 Global Breast Cancer Screening Market by Application 18
1.3.1 Global Breast Cancer Screening Market Size and Market Share Comparison
by Applications (2019-2026) 18
1.3.2 Hospital 19
1.3.3 Clinic 20
1.4 Global Breast Cancer Screening Market by Regions 21
1.4.1 Global Breast Cancer Screening Market Size (Million USD) Comparison by Regions (2019-2026) 21
1.4.2 North America (USA, Canada and Mexico) Breast Cancer Screening Status
and Prospect (2014-2026) 22
1.4.3 Europe (Germany, France, UK, Russia and Italy) Breast Cancer Screening
Status and Prospect (2014-2026) 23
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Breast Cancer Screening Status and Prospect (2014-2026) 24
1.4.5 South America (Brazil, Argentina, Colombia) Breast Cancer Screening Status and Prospect (2014-2026) 25
1.4.6 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Breast Cancer Screening Status and Prospect (2014-2026) 26
1.5 Global Market Size of Breast Cancer Screening (2014-2026) 27
Chapter 2 Market Dynamics 28
2.1 Drivers 28
2.2 Restraints 28 2.3 Opportunities 28
2.4 Porter’s Five Forces Analysis 28
2.4.1 Porter’s Five Forces Analysis 28
2.5 Key Market Strategies 29
2.5.1 Key Market Strategies, 2018 (%) 29
Chapter 3 Company Profiles 30
3.1 Hologic 30
3.1.1 Company Basic Information and Its Competitors 30
3.1.2 Hologic Product Category 30
3.1.2.1 Product A 30
3.1.2.2 Product B 30
3.1.3 Hologic Breast Cancer Screening Revenue (2018-2019) 30
3.1.4 Hologic Recent Developments 31
3.1.5 Main Business/Business Overview 31
3.2 GE Healthcare 32
3.2.1 Company Basic Information and Its Competitors 32
3.2.2 GE Healthcare Product Category 32
3.2.2.1 Product A 32
3.2.2.2 Product B 32
3.2.3 GE Healthcare Breast Cancer Screening Revenue (2018-2019) 32
3.2.4 G E He an lth care Recent Developments 33
3.2.5 Main Business/Business Overview 33
3.3 Siemen Healthineers 34
3.4 Philips Healthcare 34
3.5 Canon Medical 34
3.6 Fujifilm 34
3.7 Metaltronica 34
3.8 Sino Medical-Device 34
3.9 IMS Srl 34
Chapter 4 Global Breast Cancer Screening Market Competition, by Players 35
4.1 Global Breast Cancer Screening Market Revenue and Share by Players (2018-2019) 35
4.2 Market Concentration Rate 37
4.2.1 Top 3 Breast Cancer Screening Players Market Share 37
4.2.2 Top 5 Breast Cancer Screening Players Market Share 37
Chapter 5 Global Breast Cancer Screening Market Size by Regions 38
5.1 Global Breast Cancer Screening Market Revenue, and Market Share by Regions 38
5.2 North America Breast Cancer Screening Market Revenue, and Growth Rate (2014- 2019) 41
5.3 Europe Breast Cancer Screening Market Revenue, and Growth Rate (2014-2019) 42
5.4 Asia-Pacific Breast Cancer Screening Market Revenue, and Growth Rate (2014-2019) 43
5.5 South America Breast Cancer Screening Market Revenue, and Growth Rate (2014- 2019) 44
5.6 the Middle East & Africa Breast Cancer Screening Market Revenue, and Growth Rate (2014-2019) 45
Chapter 6 North America Breast Cancer Screening Market Revenue by Countries 46
6.1 North America Breast Cancer Screening Market Revenue, by Countries (2014-2019) 46
6.2 USA Breast Cancer Screening Market Revenue and Growth Rate (2014-2019) 48
6.3 Canada Breast Cancer Screening Market Revenue and Growth Rate (2014-2019) 49
6.4 Mexico Breast Cancer Screening Revenue and Growth Rate (2014-2019) 50
Chapter 7 Europe Breast Cancer Screening Market Revenue by Countries 51
7.1 Europe Breast Cancer Screening Market Revenue, by Countries (2014-2019) 51
7.2 Germany Breast Cancer Screening Market Revenue and Growth Rate (2014-2019) 54
7.3 France Breast Cancer Screening Market Revenue and Growth Rate (2014-2019) 55
7.4 UK Breast Cancer Screening Market Revenue and Growth Rate (2014-2019) 56
7.5 Italy Breast Cancer Screening Market Revenue and Growth Rate (2014-2019) 57
7.6 Russia Breast Cancer Screening Market Revenue and Growth Rate (2014-2019) 58
Chapter 8 Asia-Pacific Breast Cancer Screening Revenue by Countries 59
8.1 Asia-Pacific Breast Cancer Screening Market Revenue, by Countries (2014-2019) 59
8.2 China Breast Cancer Screening Market Revenue and Growth Rate (2014-2019) 62
8.3 Japan Breast Cancer Screening Market Revenue and Growth Rate (2014-2019) 63
8.4 Korea Breast Cancer Screening Market Revenue and Growth Rate (2014-2019) 64
8.5 India Breast Cancer Screening Market Revenue and Growth Rate (2014-2019) 65
Chapter 9 South America Breast Cancer Screening Revenue by Countries 66
9.1 South America Breast Cancer Screening Market Revenue, by Countries (2014-2019) 66
9.2 Brazil Breast Cancer Screening Market Revenue and Growth Rate (2014-2019) 68
9.3 Argentina Breast Cancer Screening Market Revenue and Growth Rate (2014-2019) 69
Chapter 10 Middle East & Africa Revenue Breast Cancer Screening by Countries 70
10.1 Middle East & Africa Breast Cancer Screening Market Revenue by Countries (2014- 2019) 70
10.2 Saudi Arabia Breast Cancer Screening Market Revenue and Growth Rate (2014-2019) 73
10.3 UAE Breast Cancer Screening Revenue and Growth Rate (2014-2019) 74
10.4 Egypt Breast Cancer Screening Market Revenue and Growth Rate (2014-2019) 75
10.5 South Africa Breast Cancer Screening Revenue and Growth Rate (2014-2019) 76
Chapter 11 Global Breast Cancer Screening Market Segment by Type 77
11.1 Global Breast Cancer Screening Market Revenue and Market Share by Type (2014- 2019) 77
11.2 Global Breast Cancer Screening Market Forecast by Type (2019-2026) 79
Chapter 12 Global Breast Cancer Screening Market Segment by Application 80
12.1 Global Breast Cancer Screening Market Share by Application (2014-2019) 80
12.2 Breast Cancer Screening Market Forecast by Application (2019-2026) 82
Chapter 13 Global Breast Cancer Screening Market Size Forecast (2019-2026) 83
13.1 Global Breast Cancer Screening Market Size Forecast (2019-2026) 83
13.2 Global Breast Cancer Screening Market Revenue Forecast by Regions (2019-2026) 84
13.3 North America Breast Cancer Screening Revenue Market Forecast (2019-2026) 85
13.4 Europe Breast Cancer Screening Revenue Market Forecast (2019-2026) 86
13.5 Asia-Pacific Breast Cancer Screening Revenue Market Forecast (2019-2026) 87
13.6 South America Breast Cancer Screening Revenue Market Forecast (2019-2026) 88
13.7 Middle East & Africa Breast Cancer Screening Revenue Market Forecast (2019-2026) 89
Chapter 14 Appendix 90
14.1 Methodology 90
14.2 Primary Research 90
14.3 Research Methodology 91
14.4 Assumptions & Exclusions 92
14.5 Secondary data sources 92
14.6 Disclaimer93

Do You Have Any Query Or Specific Requirement? Ask to Our Industry Expert @ https://crediblemarkets.com/enquire-request/breast-cancer-screening-market-674088?utm_source=Pramod&utm_medium=OpenPR

The report can answer the following questions:
• North America, Europe, Asia Pacific, Middle East & Africa, Latin America market size (sales, revenue and growth rate) of Breast Cancer Screening industry.
• Global major manufacturers’ operating situation (sales, revenue, growth rate and gross margin) of Breast Cancer Screening industry.
• Global major countries (United States, Canada, Germany, France, UK, Italy, Russia, Spain, China, Japan, Korea, India, Australia, New Zealand, Southeast Asia, Middle East, Africa, Mexico, Brazil, C. America, Chile, Peru, Colombia) market size (sales, revenue, and growth rate) of Breast Cancer Screening industry.
• Different types and applications of the Breast Cancer Screening industry, market share of each type, and application by revenue.
• Global market size (sales, revenue) forecast by regions and countries from 2019 to 2026 of Breast Cancer Screening industry.
• Upstream raw materials and manufacturing equipment, industry chain analysis of Breast Cancer Screening industry.
• SWOT analysis of the Breast Cancer Screening industry.
• New Project Investment Feasibility Analysis of Breast Cancer Screening industry.

Impact of Covid-19 in Breast Cancer Screening Market: Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Breast Cancer Screening market in 2020. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans, and quarantines; restaurants closed; all indoor/outdoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.

Read More: https://crediblemarkets.com/market-analysis/breast-cancer-screening-market-674088?utm_source=Pramod&utm_medium=OpenPR

Thanks for reading this article you can also get an individual chapter-wise section or region-wise report versions like North America, Europe, MEA or the Asia Pacific.

Contact Us
Credible Markets Analytics
99 Wall Street 2124 New York, NY 10005
Contact No: +1(929)-450-2887 / +1 (650)-666-4592
Email: sales@crediblemarkets.com

About US
Credible Markets has emerged as a dependable source for the market research needs of businesses within a quick time span. We have collaborated with leading publishers of market intelligence and the coverage of our reports reserve spans all the key industry verticals and thousands of micro markets. The massive repository allows our clients to pick from recently published reports from a range of publishers that also provide extensive regional and country-wise analysis. Moreover, pre-booked research reports are among our top offerings.

This release was published on openPR.